Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery-Reference-Cited by-同舟云学术

Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery

Published:2019-02 Issue:2 Volume:45 Page:204-212
ISSN:0886-3350
Container-title:Journal of Cataract and Refractive Surgery
language:en
Short-container-title:

Author:

Tyson Syd L.,Bafna Shamik,Gira Joseph P.,Goldberg Damien F.,Jones Jason J.,Jones Michael P.,Kim Janet K.,Martel Joseph M.,Nordlund Michael L.,Piovanetti-Perez Ian K.,Singh Inder Paul,Metzinger Jamie Lynne,Mulani Deepa,Sane Swati,Talamo Jonathan H.,Goldstein Michael H.

Funder

Ocular Therapeutix, Inc.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Sensory Systems,Ophthalmology,Surgery

Reference15 articles.

1. Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma.;Chang;Clin Ophthalmol,2009

2. Treatment of post-operative inflammation following cataract surgery - a review.;Dua;Eur Ophthalmic Rev,2012

3. Recovery after cataract surgery.;Porela-Tiihonen;Acta Ophthalmol,2016

4. Electronic compliance monitoring of topical treatment after ophthalmic surgery.;Hermann;Int Ophthalmol,2010

5. Evaluation of eye drop administration by inexperienced patients after cataract surgery.;An;J Cataract Refract Surg,2014

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dexamethasone Intracanalicular Insert versus Standard Topical Steroids for the Prophylaxis of Inflammation after Cataract Surgery;American Journal of Ophthalmology;2024-12

2. Advances in ophthalmic therapeutic delivery: A comprehensive overview of present and future directions;Survey of Ophthalmology;2024-11

3. Drug Delivery Systems for Glaucoma: A Narrative Review;Pharmaceuticals;2024-09-02

4. Dexamethasone Intracanalicular Insert for Clinically Significant Aqueous-Deficient Dry Eye;Ophthalmology;2024-09

5. ROS-responsive charge reversal mesoporous silica nanoparticles as promising drug delivery system for neovascular retinal diseases;Journal of Controlled Release;2024-09